WUXI BIOLOGICS
LIVE

Serial Number

98582091

Owner

WUXI BIOLOGICS IRELAND LIMITED

Attorney

Michael T. Smith

Filing Date

Jun 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

WUXI BIOLOGICS Trademark

Serial Number: 98582091 • Registration: 7875814

WUXI BIOLOGICS is a trademark filed by WUXI BIOLOGICS IRELAND LIMITED on June 3, 2024. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

WUXI BIOLOGICS IRELAND LIMITED (49 trademarks)

MULLAGHARLIN,

Entity Type: 99

Trademark Details

Filing Date

June 3, 2024

Registration Date

July 29, 2025

Goods & Services

Chemical distillation services in the field of chemical reagents; Custom manufacture of antibody drugs; Custom manufacture of biological preparations in the nature of fungicides and cancer drugs; Custom manufacture of cancer medicines; Custom manufacture of pharmaceuticals

Biological preparations for use in industry and science; biological preparations to be used for protein production, other than for medical or veterinary purposes, namely, protein for industrial use, protein in raw material form for scientific and medical research, protein arrays for scientific and medical research, proteins for use in manufacture; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; cultures of microorganisms, other than for medical and veterinary use; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes

Consulting services in the field of technological product development; Research and development of new products for others; Research and developments of new products; Scientific research and development; Pharmaceutical drug development services; Pharmaceutical research services; Biochemical research and analysis; Development of pharmaceutical preparations and medicines; Research and development services in the field of antibodies; Biological research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 29, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jul 29, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jun 25, 2025 CNTA
EXAMINER'S AMENDMENT ENTERED
Jun 25, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 25, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 24, 2025 GNFN
FINAL REFUSAL E-MAILED
Jun 24, 2025 GNFR
FINAL REFUSAL WRITTEN
Jun 24, 2025 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 20, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 20, 2025 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2025 REAP
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 17, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 17, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 17, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 17, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2024 NWOS
NEW APPLICATION ENTERED
Jun 3, 2024 NWAP